Shockwave Medical to Participate in Upcoming September Investor Conferences
August 26 2020 - 8:00AM
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the
development of Intravascular Lithotripsy (IVL) to treat complex
calcified cardiovascular disease, announced today that Shockwave
management is scheduled to speak at the following upcoming virtual
investor conferences:
- The 2020 Wells Fargo Virtual Healthcare Conference, Wednesday,
September 9, 2020, at 2:40 p.m. Eastern Time
- The Morgan Stanley Virtual 18th Annual Global Healthcare
Conference, Thursday, September 17, 2020, at 2:45 p.m. Eastern
Time
Interested parties may access live and archived webcasts of
these events on the "Investors" section of the company’s website at
https://ir.shockwavemedical.com.
About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing
products intended to transform the way calcified cardiovascular
disease is treated. The company aims to establish a new standard of
care for the interventional treatment of atherosclerotic
cardiovascular disease through differentiated and proprietary local
delivery of sonic pressure waves for the treatment of calcified
plaque, which the company refers to as Intravascular Lithotripsy
(IVL). IVL is a minimally invasive, easy-to-use and safe way to
significantly improve patient outcomes. To view an animation of the
IVL procedure and for more information, visit
www.shockwavemedical.com.
Media Contact: Scott Shadiow
+1.317.432.9210sshadiow@shockwavemedical.com
Investor Contact:Debbie Kasterinvestors@shockwavemedical.com
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Apr 2023 to Apr 2024